Aurobindo Pharma Ltd. (AUROPHARMA) Share Price Hits Fresh 52-Week High
- August 10, 2026
- Posted by: Harsh Piplani
- Category: News
Aurobindo Pharma Ltd. Share Price stood at Rs 1,664.30, up 0.20% today, after hitting a fresh 52-week high of Rs 1,671.30. Market capitalisation stood at Rs 95,570.27 crore.
Aurobindo Pharma Ltd. Share Price was at Rs 1,664.30 on 10 August 2026 at 10:16 AM IST, up Rs 3.30 or 0.20% from the previous close of Rs 1,661.00, after the stock touched a fresh 52-week high of Rs 1,671.30. With a market capitalisation of Rs 95,570.27 crore and turnover of Rs 3.76 crore so far, the stock has moved into focus in today’s Stock Market Today and Share Market Today watchlists as a verified 52 Week High stock.
The supplied data confirms the price event clearly: Aurobindo Pharma Ltd. Share Price Today opened at Rs 1,662.65, traded between Rs 1,650.00 and Rs 1,671.30, and set a new one-year high during the session. That makes this Aurobindo Pharma Ltd. Stock News item relevant not because of any stated company-specific trigger, but because fresh yearly highs often draw attention from investors tracking price action, market movers and momentum stocks.
From a financial context, the stock is currently valued at a P/E ratio of 31.12 and a P/B ratio of 0.45. Its reported ROE stands at -2.89 while ROCE is -0.26. In Univest analysis, that creates an interesting mix: Aurobindo Pharma Ltd. Share Price is making a fresh 52-week peak, but the supplied profitability ratios remain below the Healthcare sector medians. Investors tracking Aurobindo Pharma Ltd. Share Price Live and Aurobindo Pharma Ltd. Latest News may therefore want to monitor whether price strength continues to outpace the underlying return ratios and how the stock compares with Healthcare peers.
Aurobindo Pharma Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,664.3 |
| Previous Close | Rs 1,661 |
| Today's Change | +Rs 3.3 (+0.2%) |
| Day Open | Rs 1,662.65 |
| Fresh 52-Week High | Rs 1,671.3 |
| Day Low | Rs 1,650 |
| Current Volume | 22,618 |
| Turnover | Rs 3.76 crore |
| Market Capitalisation | Rs 95,570.27 crore |
Aurobindo Pharma Ltd. (AUROPHARMA) traded at Rs 1,664.3. versus the previous close of Rs 1,661, a rise of 0.2%. The stock opened at Rs 1,662.65, reached Rs 1,671.3, touched Rs 1,650. Reported volume was 22,618.
Aurobindo Pharma Ltd. Share Price Today moved in a narrow but positive range, opening at Rs 1,662.65, dipping to Rs 1,650.00, and then touching a fresh 52-week high of Rs 1,671.30 before trading at Rs 1,664.30. The move of 0.20% over the previous close confirms a new one-year high even without a large intraday percentage surge.
What exactly happened today is straightforward from the verified data. Aurobindo Pharma Ltd. Share Price opened slightly above the previous close of Rs 1,661.00 and remained active through a Rs 21.30 intraday range between the day’s low and the 52-week peak. The current price of Rs 1,664.30 kept the stock near the upper end of the session band, which is why Aurobindo Pharma Ltd. Share News has entered the list of Stocks in News and 52 Week High Stocks.
Trading participation also matters for a Share Price Update. Current volume stood at 22,618 shares, while turnover was Rs 3.76 crore. Those figures show that the move to a yearly high happened on recorded market activity rather than on a stale quote. For traders and long-term trackers alike, the day’s structure suggests the stock has managed to print a new price landmark while holding close to that zone rather than immediately surrendering it.
At the same time, the day change of Rs 3.30 indicates this was not a runaway spike. In Univest’s reading, that nuance is important. Aurobindo Pharma Ltd. Share Price Today is attracting attention because a fresh 52-week high often matters more than the size of the single-day gain. The next step is to assess whether the valuation and financial metrics add support to that market attention.
Aurobindo Pharma Ltd. (AUROPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 95,570.27 crore |
| P/E Ratio | 31.12x |
| P/B Ratio | 0.45x |
| ROE | -2.89% |
| ROCE | -0.26% |
Aurobindo Pharma Ltd. was valued at a P/E ratio of 31.12x, a P/B ratio of 0.45x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 31.12x |
| Benchmark Median P/E | 21.04x |
| Benchmark Average P/E | 71.82x |
| Benchmark P/E Range | 0x to 3,417.8x |
| Company P/B Ratio | 0.45x |
| Benchmark Median P/B | 1.89x |
| Company ROE | -2.89% |
| Benchmark Median ROE | 10.7% |
| Company ROCE | -0.26% |
| Benchmark Median ROCE | 13.16% |
| Company Market Capitalisation | Rs 95,570.27 crore |
| Benchmark Median Market Cap | Rs 130.8 crore |
Aurobindo Pharma Ltd. (AUROPHARMA) is classified under sector: Healthcare.
Aurobindo Pharma Ltd. (AUROPHARMA) has a P/E ratio of 31.12x, which is above the benchmark median of 21.04x, a difference of +47.91%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Aurobindo Pharma Ltd. (AUROPHARMA) has a ROE of -2.89%, which is below the benchmark median of 10.7%, a difference of -127.01%. Aurobindo Pharma Ltd. (AUROPHARMA) has a ROCE of -0.26%, which is below the benchmark median of 13.16%, a difference of -101.98%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 3,032.97 | 31.12 | 0.45 | -2.89 | -0.26 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,707.2 | 40.2 | 8.18 | 28.21 | 26.35 |
| Beta Drugs Ltd. | BETA | 2,631.45 | 63.43 | 6.27 | 18.65 | 22.17 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,537.93 | 33.3 | 6.87 | -2.6 | 16.92 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,513.58 | 176.28 | 3.26 | 13.9 | 12.97 |
Aurobindo Pharma Ltd. (AUROPHARMA) has a P/E ratio of 31.12x compared with the displayed peer median of 40.2x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Aurobindo Pharma Ltd. (AUROPHARMA) has a market capitalisation of Rs 95,570.27 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd. Share Price is drawing market attention because the stock has entered a fresh one-year high zone while its valuation, size and sector positioning present a more layered picture than a simple momentum move.
- Fresh price event: The stock touched a 52-week high of Rs 1,671.30 and was trading at Rs 1,664.30, up 0.20%.
- Active session data: It opened at Rs 1,662.65, traded between Rs 1,650.00 and Rs 1,671.30, with volume of 22,618 shares and turnover of Rs 3.76 crore.
- Large scale: Market capitalisation stood at Rs 95,570.27 crore, making this a sizeable Healthcare company in the Indian Stock Market.
- Mixed fundamentals: P/E was 31.12 and P/B was 0.45, while ROE and ROCE were -2.89 and -0.26 respectively.
- Sector context: The company’s P/E is above the Healthcare median of 21.04, but its P/B is below the sector median of 1.89.
- Peer view: Compared with supplied peers, the company is much larger by market cap but weaker on the reported return ratios.
About Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd. is tracked here as a listed Healthcare company under the symbol AUROPHARMA. The supplied market data places it within the Healthcare sector, and several of the comparison companies fall under Pharmaceuticals & Drugs, which helps frame the stock within a broader healthcare and pharma market context.
From a market perspective, Aurobindo Pharma Ltd. Share Price carries relevance because the company’s market capitalisation of Rs 95,570.27 crore is far larger than the median and average figures supplied for the Healthcare benchmark universe. That makes the stock a notable name when it appears in NSE News, BSE News, Stock Updates and 52 Week High Stocks screens.
For readers following Aurobindo Pharma Ltd. Latest News and Aurobindo Pharma Ltd. Company News, the most reliable company overview in this dataset is therefore its listed identity, sector classification and comparative standing. Univest focuses on the verified price, valuation and sector data available here, which already shows why the stock is being closely watched in the market today.
Track Aurobindo Pharma Ltd. Share Price on Univest
Use Aurobindo Pharma Ltd. (AUROPHARMA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Investors can track Aurobindo Pharma Ltd. Share Price on Univest for live share price moves, 52 Week High and 52 Week Low levels, market insights, valuation ratios, shareholding pattern updates when available, and broader stock analysis tools. Univest also helps users monitor Aurobindo Pharma Ltd. Share Price Today alongside market cap, peer comparison and sector benchmarks in one place.
For readers following Aurobindo Pharma Ltd. Share Price Live, Aurobindo Pharma Ltd. Stock News and Aurobindo Pharma Ltd. Share Price Update, the key advantage is having verified market data organised around price action, fundamental analysis and sector analysis. Univest coverage is especially useful when a stock enters a new yearly high zone and investors want context rather than only a headline move.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the current Aurobindo Pharma Ltd. Share Price?
Ans. Aurobindo Pharma Ltd. Share Price was Rs 1,664.30 at 10:16 AM IST on 10 August 2026. The stock was up Rs 3.30, or 0.20%, from the previous close of Rs 1,661.00 during the session.
Why is Aurobindo Pharma Ltd. Share Price in focus today?
Ans. Aurobindo Pharma Ltd. Share Price is in focus because it touched a fresh 52-week high of Rs 1,671.30. Even though the day gain was 0.20%, a new one-year high often attracts added market attention and stock news coverage.
What was the 52-week high for Aurobindo Pharma Ltd. today?
Ans. The fresh 52-week high for Aurobindo Pharma Ltd. was Rs 1,671.30. The stock later traded at Rs 1,664.30, showing it remained close to the day’s peak after setting the new yearly high in trade.
How did Aurobindo Pharma Ltd. Share Price trade during the session?
Ans. Aurobindo Pharma Ltd. Share Price opened at Rs 1,662.65, moved to a day low of Rs 1,650.00 and a day high of Rs 1,671.30. That intraday range shows the stock tested higher levels while staying in positive territory.
What were the trading volume and turnover for Aurobindo Pharma Ltd.?
Ans. The stock recorded current volume of 22,618 shares and turnover of Rs 3.76 crore. These figures show that the move to the fresh 52-week high happened with visible trading activity during the session.
What is the market capitalisation of Aurobindo Pharma Ltd.?
Ans. Aurobindo Pharma Ltd. had a market capitalisation of Rs 95,570.27 crore in the supplied data. That is far above the Healthcare sector benchmark median of Rs 130.8 crore and average of Rs 460.68 crore.
What do the valuation ratios say about Aurobindo Pharma Ltd.?
Ans. Aurobindo Pharma Ltd. was trading at a P/E ratio of 31.12 and a P/B ratio of 0.45. Its P/E is above the Healthcare median of 21.04, while its P/B is below the sector median of 1.89.
How profitable is Aurobindo Pharma Ltd. based on the supplied ratios?
Ans. The supplied profitability ratios show ROE of -2.89 and ROCE of -0.26 for Aurobindo Pharma Ltd. Both are below the Healthcare sector medians of 10.7 for ROE and 13.16 for ROCE.
How does Aurobindo Pharma Ltd. compare with peers?
Ans. Compared with supplied peers, Aurobindo Pharma Ltd. is much larger by market cap at Rs 95,570.27 crore. Its P/E of 31.12 is lower than some peers, but its ROE and ROCE are weaker than most listed comparables.
What should investors monitor next in Aurobindo Pharma Ltd. Stock News?
Ans. Investors may monitor whether Aurobindo Pharma Ltd. Share Price sustains near the 52-week high of Rs 1,671.30 and how valuation and profitability metrics evolve. Current focus areas include P/E 31.12, P/B 0.45, ROE -2.89 and ROCE -0.26.
